David Hanley, M.D.
Dr. Hanley’s clinical research interests are in the endocrinology of normal and abnormal calcium metabolism, and metabolic bone disease, including osteoporosis. He is the Calgary centre director for the Canadian Multicentre Osteoporosis Study, a prospective population-based study of the epidemiology of osteoporosis and fractures. More recently he and Dr. Steve Boyd have been co-principal investigators of a clinical trial assessing the effect of high doses of vitamin D on bone.
Dr. Hanley is a Past-President of the Canadian Society of Endocrinology and Metabolism, and a member of Osteoporosis Canada’s Scientific Advisory Council, which he chaired from 1991-1995. He is the founder of the Calgary health region’s Osteoporosis Centre. With respect to vitamin D, Dr. Hanley chaired Osteoporosis Canada’s Vitamin D Guidelines committee, and has been a coauthor of the first three iterations of Osteoporosis Canada’s Clinical Practice Guidelines. He was also on the Endocrine Society’s Guidelines committee for treatment of vitamin D deficiency.